Hi Phylogica,
If Phylogica's FPPs allow delivery of therapeutic cargoes i.e., enzymes, peptides/proteins, scaffolds, immunotoxins, antibodies, Oligos etc.. into specific cell types (kidney, blood, breast, bone, dentric cells, liver, muscle etc), then this experiment could potentially have a significant positive implication for the melanoma cancer vaccine project you are progressing, as the company have now shown, that not only are you able to deliver the therapeutic cargo, in this case, the enzyme, into the cytoplasm, but more importantly, directly into the kidney cell's nucleus. Hope I'm on the right track.
Tony
Hi Phylogica, If Phylogica's FPPs allow delivery of therapeutic...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |